| Ex. AGY-ST-HEALTH-BOARDS-015 | Board of Pharmacy compilation, 'COVID-19 Response Efforts' (updated Oct. 6, 2025): rescinded and continuing COVID-19 waivers, resolutions and emergency rules with issue and rescission datesCOVID-19 Response Efforts: Rescinded COVID-19 Waivers and Guidance; COVID-19 Immunization Waivers; COVID-19 Waivers and Resolutions for… | State of Ohio Board of Pharmacy | State of Ohio Board of Pharmacy; State levelSector regulator | Oct. 6, 2025 | | Health care ordersSupply chainOther | Confirmed from a secondary source | |
| Ex. AGY-ST-HEALTH-BOARDS-016 | Emergency Rule, 22 Tex. Admin. Code § 291.30 (Medication Limitations)22 TAC § 291.30. Medication Limitations (chloroquine and hydroxychloroquine dispensing restricted) | Texas State Board of Pharmacy (emergency board business meeting of Mar. 20, 2020) | Texas State Board of Pharmacy; State levelSector regulator | Mar. 20, 2020 | 2020 Q22020 Q3 | Health care ordersSupply chain | Primary source read | |
| Ex. AGY-ST-HEALTH-BOARDS-019 | Minutes, Emergency Board Business Meeting held via videoconference, Mar. 20, 2020Minutes of the Emergency Board Business Meeting under the authority of the Governor's Proclamation of Emergency Disaster: adoption of… | Texas State Board of Pharmacy | Texas State Board of Pharmacy; State levelSector regulator | Mar. 20, 2020 | 2020 Q2 | Health care ordersSupply chainOther | Primary source read | |
| Ex. AGY-ST-HEALTH-BOARDS-022 | DCA Waiver DCA-20-03, Order Waiving Restrictions on Nursing Student Clinical HoursOrder Waiving Restrictions on Nursing Student Clinical Hours (Board-approved clinical setting and 75 percent direct-patient-care… | Kimberly Kirchmeyer, Director, Department of Consumer Affairs | California Department of Consumer Affairs, Director (Board of Registered Nursing); State levelSector regulator | Apr. 3, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Schools and child careHealth care ordersOther | Primary source read | |
| Ex. AGY-ST-HEALTH-BOARDS-017 | TSBP Guidance Statements re: COVID-19 (Issued May 15, 2020)Guidance Statements re: COVID-19: dispensing in compliance with Emergency Board Rule 291.30 (hydroxychloroquine); diagnosis verification… | Texas State Board of Pharmacy | Texas State Board of Pharmacy; State levelSector regulator | May 15, 2020 | 2020 Q22020 Q3 | Health care ordersSupply chain | Primary source read | |